Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-027756
Filing Date
2025-02-26
Accepted
2025-02-26 16:15:35
Documents
91
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rlay-20241231.htm   iXBRL 10-K 3742577
2 EX-19.1 rlay-ex19_1.htm EX-19.1 313282
3 EX-23.1 rlay-ex23_1.htm EX-23.1 6086
4 EX-31.1 rlay-ex31_1.htm EX-31.1 18021
5 EX-31.2 rlay-ex31_2.htm EX-31.2 17837
6 EX-32.1 rlay-ex32_1.htm EX-32.1 15810
7 GRAPHIC img68967610_0.jpg GRAPHIC 95397
8 GRAPHIC img68967610_1.jpg GRAPHIC 306135
9 GRAPHIC img68967610_2.jpg GRAPHIC 36467
10 GRAPHIC img68967610_3.jpg GRAPHIC 331906
11 GRAPHIC img68967610_4.jpg GRAPHIC 263236
12 GRAPHIC img68967610_5.jpg GRAPHIC 87419
13 GRAPHIC img68967610_6.jpg GRAPHIC 67985
14 GRAPHIC img191250235_0.jpg GRAPHIC 8367
  Complete submission text file 0000950170-25-027756.txt   17862897

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rlay-20241231.xsd EX-101.SCH 1890301
94 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20241231_htm.xml XML 2864378
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39385 | Film No.: 25670253
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)